CRISTIANE VALVERDE WENCESLAU;KERKIS IRINA;FUNDACAO BUTANTAN;AVITA INTERNATIONAL LTD.
发明人:
KERKIS IRINA,CRISTIANE VALVERDE WENCESLAU
申请号：
IL26162318
公开号：
IL261623D0
申请日:
2018.09.05
申请国别(地区):
IL
年份:
2018
代理人:
摘要：
The invention provides a method of producing human immature dental pulp stem cells (hIDPSCs) expressing CD44 and CD13 and lacking expression of CD146. The invention also provides compositions for use in the treatment of a neurological disease or condition selected from the group consisting of Parkinson's disease (PD), multiple sclerosis, 5 amyotrophic lateral sclerosis (ALS), stroke, autoimmune encephalomyelitis, diabetic neuropathy, glaucomatous neuropathy, Alzheimer's disease, Huntington's disease (HD), autism, schizophrenia, stroke, ischemia, a motor disorder, and a convulsive disorder.
